Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Biolase laser receives FDA OK for first nondental surgery

Facebook Twitter LinkedIn Email Comments
Dental laser maker Biolase Inc.’s WaterLase iPlus all-tissue laser has been cleared by the FDA for soft-tissue use in orthopedic and podiatric surgery. This is the first nondental clearance for its flagship product.

Biolase Chairman and CEO Federico Pignatelli said the approval expands the product into two markets, each with tremendous potential. “Just the top 10 orthopedic surgical soft-tissue procedures, for example, offer a $2.6 billion market opportunity for our WaterLase technology.”

The iPlus was cleared for incision, excision, resection, ablation, vaporization, coagulation and hemostasis, with or without an arthroscope, in contact and noncontact with tissue, in orthopedic and podiatric surgery, including soft and cartilaginous tissue in small and large joints.

Jul 2013
Amado CarinoAmericasBiolaseBiophotonicsBusinessFDAFederico PignatelliimagingRapidScanWaterLase iPluslasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.